Purple Biotech (PPBT)
(Delayed Data from NSDQ)
$2.97 USD
-0.14 (-4.50%)
Updated Nov 4, 2024 03:59 PM ET
After-Market: $2.96 -0.01 (-0.34%) 4:24 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.97 USD
-0.14 (-4.50%)
Updated Nov 4, 2024 03:59 PM ET
After-Market: $2.96 -0.01 (-0.34%) 4:24 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Zacks News
What Makes Purple Biotech (PPBT) a New Buy Stock
by Zacks Equity Research
Purple Biotech (PPBT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Purple Biotech Ltd. Sponsored ADR (PPBT) Could be Great Choice for a Bottom Fisher
by Zacks Equity Research
Purple Biotech Ltd. Sponsored ADR (PPBT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.